ICU Medical (ICUI)
(Delayed Data from NSDQ)
$124.47 USD
-1.39 (-1.10%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $124.43 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$124.47 USD
-1.39 (-1.10%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $124.43 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Zacks News
4 Medical Device Stocks to Top Q3 Earnings
by Zacks Equity Research
A look at how medical device players are poised for this earnings season.
Pfizer (PFE) Beats on Q3 Earnings, Raises 2017 EPS View
by Zacks Equity Research
Pfizer (PFE) beat expectations for earnings while delivering in-line revenues in Q3. It raised its adjusted earnings guidance while tightening revenue expectations for 2017.
Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact
by Zacks Equity Research
Pfizer, Inc. (PFE) reported first-quarter 2017 adjusted earnings per share of 69 cents, which beat the Zacks Consensus Estimate of 67 cents by 3%.
MedTech Stocks' Q4 Earnings on Mar 1: ICUI, GKOS & EGRX
by Zacks Equity Research
Let's take a look at the major MedTech stocks within the broader medical community, slated to release their reports on Mar 1.
Walgreens Teams Up with Fedex to Boost Retail Performance
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) recently inked a multi-year partnership agreement with global express delivery services company FedEx Corporation (FDX).
Align Poised On Global Expansion & Invisalign Teen Growth
by Zacks Equity Research
On Jan 10, 2017, we issued an updated research report on California-based Align Technology Inc. (ALGN).
Illumina (ILMN) Launches NovaSeq Series for $100 Genome
by Zacks Equity Research
Illumina, Inc. (ILMN) recently unveiled the NovaSeq Series, a scalable sequencing solution expected to enable a $100 genome.
QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite
by Zacks Equity Research
QIAGEN N.V. (QGEN) recently announced the acquisition of Cary, NC-based OmicSoft Corporation.
LLabCorp: Reimbursement Scenario a Drag Amid Other Woes
by Zacks Equity Research
On Jan 09, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH) or LabCorp.
ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders
by Zacks Equity Research
ResMed Inc. (RMD) recently formed a joint venture with renowned surgeon and television host Dr. Mehmet Oz and private equity firm Pegasus Capital Advisors, L.P.
Myriad Genetics: Evidence Street Reviews EndoPredict Test
by Zacks Equity Research
Myriad Genetics, Inc. (MYGN) recently announced that Blue Cross Blue Shield Association's technical assessment provider Evidence Street has reviewed its EndoPredict assay.
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.10 in first-quarter fiscal 2017, up 6.8% from the year-ago quarter.
Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite
by Zacks Equity Research
Bruker Corporation (BRKR) recently announced the buyout of Hennigsdorf, Germany-based InVivo Biotech Services GmbH.
Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging
by Zacks Equity Research
Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH.
ResMed Achieves Key Milestone in Sleep-Disordered Breathing
by Zacks Equity Research
After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.
4 Medical Device Stocks on a Bull Run this Earnings Season
by Zacks Equity Research
The expected positive third-quarter performance by the broader Medical sector is something investors definitely need to muse on.